Skip to main content
TipRanks
Go Ultimate75% OFF

Procter & Gamble (PG) AI Stock Analysis

16,655 Followers
PG

Procter & Gamble

(NYSE:PG)

Select Model
Rating:80Outperform
Price Target:$185.00â–²(8.95% Upside)
Action:reiterated
Date:10/30/26

PG scores well primarily on strong, steady financial performance (durable margins and cash generation) and supportive technicals (price above major moving averages with positive MACD). The score is tempered by a premium valuation for modest growth and an earnings outlook that, while stable and confident, includes sizable cost/FX/interest headwinds and anticipated volatility.

Positive Factors
Branded consumer staples scaleP&G’s broad portfolio of trusted, frequently purchased products supports recurring demand across household, personal care, health, and family categories. Global distribution and scale in procurement, manufacturing, advertising, and innovation reinforce durable competitive advantages.
Negative Factors
Limited underlying growth outlookThe modest sales and earnings outlook suggests P&G remains a mature, slow-growing business with limited near-term acceleration. Low growth can constrain operating leverage and makes continued innovation, share defense, and productivity execution important to sustaining returns.

Procter & Gamble Key Performance Indicators (KPIs)

Revenue by SegmentShows sales performance across various divisions, indicating which areas are growing or declining and how the company is diversifying its revenue streams.

$0.00$5.00B$10.00B$15.00B$20.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Fabric & Homecare is the steady engine driving P&G’s topline, while Beauty and Grooming show a clear recovery consistent with management’s innovation wins (Tide, SK‑II, Pantene). Baby/Feminine is broadly stable but family‑care pockets remain a dragged performer, matching the call’s weakness notes. Healthcare is the most volatile segment, rolling off late‑2025 peaks. Rising corporate/other allocations plus restructuring and inventory/timing effects mean revenue gains are selective — margin and EPS upside will depend on productivity offsetting input‑cost headwinds.

Data provided by:The Fly

Procter & Gamble (PG) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%PG+18.87%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$393.56B
Dividend Yield
2.55%
Average Volume (3M)
9.31M
Price to Earnings (P/E)
25.2
Beta (1Y)
0.19
Revenue Growth
3.52%
EPS Growth
-3.74%
Country
US
Employees
104,000
Sector
Consumer Defensive
Sector Strength
62
Industry
Household & Personal Products

Procter & Gamble Business Overview & Revenue Model

Company Description

The Procter & Gamble Company, commonly referred to as P&G, is a global enterprise that supplies a broad spectrum of branded consumer products to markets worldwide. The company's operations are divided into five main business divisions: Beauty; Groomi...

How the Company Makes Money

P&G primarily makes money by manufacturing and selling branded consumer products to retailers, distributors, and e-commerce platforms, as well as directly to consumers in some markets. Its revenue model is largely volume-and-price driven: it generate...

Procter & Gamble Earnings Call Summary

Earnings Call Date:Oct 22, 2026(Q1-2027)|% Change Since:8.98%|Next Earnings Date:Jan 20, 2027
Earnings Call SentimentPositive

The call was broadly positive. P&G reported 4.0% organic sales growth, volume-led momentum across all categories and regions, improving share trends, strong performance in North America and China, and maintained its fiscal 2027 guidance. However, the outlook includes significant commodity, freight, foreign-exchange, interest, and geopolitical headwinds, along with margin pressure, flat aggregate market share, and unresolved challenges in several categories. Management remained confident in the company's ability to execute, but emphasized that results would be volatile and would not progress in a straight line.

Positive Updates

Organic Sales Growth Accelerated
First-quarter organic sales increased 4.0% versus the prior year, with volume up 2.4 points, pricing up 0.4 points, and mix up more than 1 point. Management described the balance across top-line drivers as solid, with the majority of growth driven by volume.

Negative Updates

Higher Cost and Freight Headwinds
P&G expects higher costs from raw materials, energy, and freight, primarily in North America, with these headwinds expected to increase over the next few quarters. Core gross margin declined 150 basis points and core operating margin declined 80 basis points versus the prior year.

Company Guidance

For fiscal 2027, P&G is maintaining guidance for sales growth of 1% to 3%, core EPS growth of 0% to 3% versus prior year, or $6.89 to $7.11 per share, and free cash flow productivity at 85% to 90%; top line guidance includes roughly 30% to 50% basis points headwinds from product and market exits, the outlook includes a cost headwind of approximately $1.4 billion after tax assuming an effective Brent crude oil price of $100 a barrel, an expected foreign exchange headwind of approximately $50 million after tax, approximately $300 million of higher net interest expense after tax, around €150 million higher due to debt issuance related to recent M&A activity, and $150 million after tax of lower non operating income; the core effective tax rate is expected to be in the range of 20% to 21%, combined input costs, foreign exchange items below the operating line are expected to be roughly $1.9 billion after tax headwind of earnings, or $0.79 per share and 11% of fiscal 2026 core EPS, capital spending is expected to be between 4.5% to 5.5% of sales, dividends are expected to exceed $10 billion, approximately $5 billion of common stock is expected to be repurchased, and the company plans to return $15 billion of cash to shareowners; P&G expects H1 to be at about 3% organic sales growth, with slight acceleration in half 2, and category value growth of 2.5% to 3%.

Procter & Gamble Financial Statement Overview

Summary

High-quality, defensive fundamentals: consistently strong profitability (gross margins ~47%–51%, net margins ~18%–19%), solid EBIT margins (low-to-mid 20s), and reliable cash generation with strong free cash flow conversion (~77%–83% of net income). Offsetting factors are modest recent revenue growth (~low single-digit; ~1% TTM) and moderately rising leverage (debt-to-equity edging higher in TTM).

Income Statement

88Very Positive

Balance Sheet

78Positive

Cash Flow

82Very Positive
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue87.92B87.03B84.28B84.04B82.01B80.19B
Gross Profit43.77B43.67B43.12B43.19B39.25B38.03B
EBITDA24.48B24.41B23.92B22.58B21.77B21.24B
Net Income16.03B16.05B15.97B14.88B14.65B14.74B
Balance Sheet
Total Assets133.13B126.52B125.23B122.37B120.83B117.21B
Cash, Cash Equivalents and Short-Term Investments15.37B9.94B9.56B9.48B8.25B7.21B
Total Debt38.92B35.03B35.46B33.37B35.42B32.29B
Total Liabilities77.80B72.21B72.95B71.81B73.76B70.35B
Stockholders Equity55.10B54.31B52.01B50.29B46.78B46.59B
Cash Flow
Free Cash Flow15.34B15.15B14.04B16.52B13.79B13.57B
Operating Cash Flow19.91B19.56B17.82B19.85B16.85B16.72B
Investing Cash Flow-4.55B-4.62B-3.82B-3.50B-3.50B-4.42B
Financing Cash Flow-11.08B-14.46B-14.04B-14.86B-12.15B-14.88B

Procter & Gamble Technical Analysis

Technical Analysis SentimentPositive
Last Price169.80

Price Trends

50DMA153.59Positive
100DMA149.47Positive
200DMA147.99Positive

Market Momentum

MACD4.45Negative
RSI69.24Neutral
STOCH77.48Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PG, the sentiment is Positive. The current price of 169.80 is above the 20-day moving average (MA) of 163.19, above the 50-day MA of 153.59, and above the 200-day MA of 147.99, indicating a bullish trend. The MACD of 4.45 indicates Negative momentum. The RSI at 69.24 is Neutral, neither overbought nor oversold. The STOCH value of 77.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PG.

Procter & Gamble Risk Analysis

Procter & Gamble disclosed 16 risk factors in its most recent earnings report. Procter & Gamble reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

3 New Risks
1.Item 2.Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities ISSUER PURCHASES OF EQUITY SECURITIESPeriodTotal Number of Shares Purchased (1)Average Price Paid per Share (2)Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3)Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program1/01/2026 - 1/31/2026- - - (3)2/01/2026 - 2/28/20263,911,417 $159.79 3,911,417 (3)3/01/2026 - 3/31/2026- - - (3)Total3,911,417 $159.793,911,417 (3)Q1, 2026
2.Item 5.Other InformationQ1, 2026
3.Item 2.Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities ISSUER PURCHASES OF EQUITY SECURITIESPeriodTotal Number of Shares Purchased (1)Average Price Paid per Share (2)Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3)Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program10/01/2025 - 10/31/2025- $- - (3)11/01/2025 - 11/30/20254,242,794 147.294,242,794 (3)12/01/2025 - 12/31/202511,303,929 143.7211,303,929 (3)Total15,546,723 $144.7015,546,723 (3)Q4, 2025

Procter & Gamble Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

PG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
PGPG80Outperform$393.56B25.1629.55%2.55%3.52%-3.74%
CHDCHD78Outperform$26.67B34.6618.21%1.09%1.70%2.07%
KMBKMB69Neutral$67.15B11.02162.62%4.66%-8.38%67.47%
CLCL67Neutral$79.23B38.721135.82%2.12%5.91%-28.30%
ULUL64Neutral$141.97B14.0658.26%3.25%-17.45%8.84%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%

* Consumer Defensive Sector Average

Performance Comparison

0%20%PGCHDCLKMBULDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
PG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
PGProcter & Gamble Company169.8028.0919.82%
CHDChurch & Dwight Company113.0030.9837.77%
CLColgate-palmolive Company99.6722.7129.50%
KMBKimberly Clark109.4310.8210.97%
ULUnilever plc66.214.857.90%

Procter & Gamble Corporate Events

Business Operations and StrategyPrivate Placements and Financing

Procter & Gamble Completes $4 Billion Senior Notes Offering

Positive
Oct 30, 2026

On October 30, 2026, Procter & Gamble closed an underwritten public offering of senior notes totaling $4 billion across four tranches, with maturities ranging from 2031 to 2056 and coupons between 5.125% and 5.900%. The multi-maturity issuance, execu...

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures

Procter & Gamble Posts Solid Fiscal Q1 2027 Results

Positive
Oct 22, 2026

Procter & Gamble reported first-quarter fiscal 2027 results on October 22, 2026, delivering 4.0% organic sales growth, driven by 2.4% volume, modest pricing and mix gains, despite a volatile macro backdrop and rising cost headwinds. Core earnings per...

Other

Procter & Gamble Reports Security Holder Voting Outcomes

Neutral
Oct 16, 2026

Procter & Gamble did not provide substantive content in this release, leaving key details about the company’s current initiatives, products, or strategic focus unstated. As a result, there is no additional context on how its consumer goods operations...

Regulatory Filings and Compliance

Procter & Gamble Issues Regulation FD Disclosure Update

Neutral
Oct 13, 2026

Procter & Gamble issued a news release, but the provided text does not contain any substantive information about the announcement’s content, timing, or operational implications. Without additional details, it is not possible to assess the impact on t...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 30, 2026